| Marker | Gabriel optimal | Typical lab range | Functional range |
|---|---|---|---|
| Hematocrit Men | 40 to 48 % | 37.5 to 51 | 40 to 48 |
| Hematocrit Women | 37 to 44 % | 34 to 46.6 | 37 to 44 |
Why TRT raises hematocrit
Testosterone stimulates red blood cell production. The exact mechanism isn't settled; proposed reasons include lower hepcidin (which frees up iron) and changes in erythropoietin, the hormone that drives red cell production.
- Form matters most. Short-acting injections (cypionate and enanthate) cause big swings in testosterone and carry the highest risk. In one comparison using a 50% cutoff, high hematocrit occurred in about 67% of injection users, 35% of pellet users and 13% of gel users.
- Other causes add up: smoking, sleep apnea, obesity and SGLT2 inhibitor diabetes drugs also raise hematocrit.
- Dehydration can make a single reading look higher. Read about the test itself in the hematocrit blood test guide.
How high is too high?
| Hematocrit (men) | What it can mean |
|---|---|
| 40% to 48% | Gabriel optimal range for men |
| Above the lab's upper limit (often 50% to 52%) | Above normal for that lab; the upper limit varies from 48% to 54% between labs |
| Above 48% before starting (50% at altitude) | The Endocrine Society advises against starting TRT |
| Above 54% on TRT | The Endocrine Society advises withholding testosterone until it falls, then resuming at a lower dose |
The full range table for hematocrit is below. A single high value is worth repeating, well hydrated, before any change.
What clinicians do about it
- Recheck the result and the original reason for TRT.
- Address other causes: stop smoking, screen for or treat sleep apnea, work on weight, and review medications.
- Adjust the testosterone: a lower dose, a longer gap between injections, or a switch to a steadier form such as a gel.
- Pause therapy above 54%, per the Endocrine Society, then restart lower once it normalizes.
- Phlebotomy (removing blood) is used by some clinicians; the Endocrine Society calls it effective. A 2025 review argues against routine blood removal unless a bone marrow cause is found, because of a possible clotting concern. Views differ, so ask your prescriber why they recommend one approach.
Get care promptly for leg swelling or pain, or breathing trouble. Call 911 for chest pain, sudden shortness of breath, or signs of a stroke such as face drooping, arm weakness or trouble speaking.
Can you donate blood on TRT?
Sometimes. Rules differ by blood center, and every donor is screened first, so ask your local center before you go. In one large U.S. blood service, people on TRT made up 1.6% of donors. Routine whole blood donation has a minimum gap of 56 days.
Tell the blood center you take testosterone, and check its rules first. Donating isn't a substitute for your prescriber's plan, and a 2025 review discourages using regular donation to manage TRT hematocrit without your clinician's input.
How often to check
The Endocrine Society calls for hematocrit checks during the first year of TRT, along with testosterone and PSA. A 2017 review describes checking every 3 to 6 months. You can upload any lab report and Gabriel explains it in plain words, and a free Gabriel account pays cost-plus prices on lab tests. See also TRT side effects.
Common questions
What hematocrit is too high on TRT?
The Endocrine Society advises withholding testosterone above 54% until it falls, then restarting at a lower dose. Many labs flag values above about 50% to 52%.
Does donating blood lower hematocrit on TRT?
Removing blood lowers hematocrit for a time. Some clinicians use it; a 2025 review cautions against it as routine. Ask your prescriber first.
Which form of TRT raises hematocrit least?
Steadier forms such as gels and patches raise it less than short-acting injections, according to a 2017 review. Your clinician decides the form.
Can dehydration cause high hematocrit?
Yes. Less plasma makes red cells a bigger share of the sample, so recheck when well hydrated.
Is high hematocrit on TRT dangerous?
Thicker blood is a plausible clot risk, and population studies link high hematocrit to clots, but direct proof in TRT users is limited. That's why clinicians act on it.
Sources
- Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline Journal of Clinical Endocrinology & Metabolism (Bhasin et al., 2018)
- Erythrocytosis following testosterone therapy Sexual Medicine Reviews (Ohlander et al., 2017), via PubMed Central
- Testosterone-induced erythrocytosis: addressing the challenge of metabolic syndrome and widely prescribed SGLT2-inhibitor drugs Endocrine Connections (Tramontana et al., 2025), via PubMed Central
- The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization Transfusion (Hazegh et al., 2020), via PubMed Central
- Testosterone replacement therapy (TRT) Cleveland Clinic
This guide is general information, not medical advice. It does not replace a visit with a licensed clinician. Gabriel membership is not health insurance.